CHIMERIX INC. - COMMO
0.9050
27-November-24 16:45:00
15 minutes delayed
Stocks
+0.0009
+0.10%
Today's range
0.9000 - 0.9395
ISIN
N/A
Source
NASDAQ
-
04 Jun 2021 14:10:15 By Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies Virtual Healthcare Conference
25 May 2021 08:00:02 By Nasdaq GlobeNewswire
-
19 May 2021 17:01:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Cowen and Company 2nd Annual Virtual Oncology Innovation Summit
13 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2021 Financial Results and Provides Operational Update
06 May 2021 07:00:03 By Nasdaq GlobeNewswire
-
29 Apr 2021 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix Appoints Vicki Vakiener to Board of Directors
26 Apr 2021 07:00:01 By Nasdaq GlobeNewswire
-
08 Apr 2021 16:01:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Virtual H.C. Wainwright Global Life Sciences Conference
02 Mar 2021 07:00:02 By Nasdaq GlobeNewswire
-
25 Feb 2021 07:00:02 By Nasdaq GlobeNewswire
-
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
25 Feb 2021 07:00:02 By Nasdaq GlobeNewswire
-
18 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
25 Jan 2021 17:44:14 By Nasdaq GlobeNewswire
-
Chimerix Announces Pricing of Public Offering of Common Stock
20 Jan 2021 20:02:52 By Nasdaq GlobeNewswire
-
Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock
19 Jan 2021 16:18:46 By Nasdaq GlobeNewswire
-
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
08 Jan 2021 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Virtual H.C. Wainwright BioConnect 2021 Conference
06 Jan 2021 08:00:01 By Nasdaq GlobeNewswire